AUROBINDO PHARMA LTD. (AUROPHARMA)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 6,472.96 6,850.52 7,219.42 7,351.78 7,580.15 7,567.02 7,796.07 7,978.52 8,382.12 7,868.14 8,285.70 8,645.90
YOY Revenue Growth % 11.42% 9.86% 25.79% 14.74% 17.1% 10.46% 7.99% 8.53% 10.58% 3.98% 6.28% 8.36%
Other Income 134.91 116.33 186.98 162.52 135.62 220.93 136.00 157.29 134.81 105.30 120.59 187.64
Total Income 6,607.87 6,966.85 7,406.40 7,514.30 7,715.77 7,787.95 7,932.07 8,135.81 8,516.93 7,973.44 8,406.29 8,833.54
Total Expenses + 5,210.38 5,301.27 5,318.15 5,275.42 5,481.34 5,341.43 5,761.51 5,813.87 7,149.65 6,768.56 7,132.03 7,430.06
Cost of Materials Consumed 2,670.57 2,756.83 2,708.91 2,675.52 2,634.88 2,466.66 2,741.85 2,728.74 2,799.51 2,535.16 2,509.80 2,754.88
Employee Benefit Expense 851.90 951.97 954.97 989.68 1,026.32 1,071.95 1,109.48 1,131.55 1,162.64 1,228.80 1,277.33 1,310.06
Other Expenses 1,687.91 1,592.47 1,654.27 1,610.22 1,820.14 1,802.82 1,910.18 1,953.58 1,999.68 1,797.09 1,991.41 2,081.29
Operating Profit 1,262.58 1,549.25 1,901.27 2,076.36 2,098.81 2,225.59 2,034.56 2,164.65 1,232.47 1,099.58 1,153.67 1,215.84
OPM % 19.5% 22.6% 26.3% 28.2% 27.7% 29.4% 26.1% 27.1% 14.7% 14% 13.9% 14.1%
Profit Before Tax + 735.92 814.84 1,074.74 1,265.01 1,242.56 1,325.28 1,207.16 1,198.26 1,367.28 1,204.88 1,274.26 1,338.15
Tax Expense 230.01 245.13 322.80 325.04 335.21 407.06 390.21 352.69 464.45 380.68 426.13 428.35
Tax % 31.3% 30.1% 30% 25.7% 27% 30.7% 32.3% 29.4% 34% 31.6% 33.4% 32%
Profit After Tax 505.91 569.71 751.94 939.97 907.35 918.22 816.95 845.57 902.83 824.20 848.13 909.80
EPS (Basic) 8.64 9.74 12.83 16.04 15.51 15.69 14.00 14.56 15.56 14.20 14.61 15.67

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
Revenue from Operations 31,723.73 29,001.87 24,855.38 23,455.49 24,774.63 23,098.50 16,499.84
YOY Revenue Growth % 9.39% 16.68% 5.97% -5.32% 7.26% 39.99% -
Other Income 621.85 557.38 290.59 320.35 380.84 86.20 101.98
Total Income 32,345.58 29,559.25 25,145.97 23,775.84 25,155.47 23,184.70 16,601.82
Total Expenses + 27,247.60 21,332.11 19,495.99 16,300.27 17,856.01 16,263.65 11,604.71
Cost of Materials Consumed 10,736.76 10,776.14 9,652.51 7,371.83 8,317.27 7,724.98 5,629.37
Employee Benefit Expense 4,475.62 3,922.94 3,522.25 3,450.92 3,535.02 3,219.18 2,130.84
Other Expenses 7,639.08 6,633.03 6,321.23 5,477.52 6,003.72 5,319.49 3,844.50
Operating Profit 4,476.13 7,669.76 5,359.39 7,155.22 6,918.62 6,834.85 4,895.13
OPM % 14.1% 26.4% 21.6% 30.5% 27.9% 29.6% 29.7%
Profit Before Exceptional 5,097.98 4,589.01 2,624.17 3,531.96 4,584.38 3,784.32 3,238.06
Exceptional Items 0.00 -191.86 0.00 -127.97 2,814.58 -26.13 0.00
Profit Before Tax + 5,097.98 4,397.15 2,624.17 3,403.99 7,398.96 3,758.19 3,238.06
Tax Expense 1,614.41 1,228.18 696.52 756.88 2,065.13 928.68 815.14
Tax % 31.7% 27.9% 26.5% 22.2% 27.9% 24.7% 25.2%
Profit After Tax 3,483.57 3,168.97 1,927.65 2,647.11 5,333.83 2,829.51 2,422.92
EPS (Basic) 59.81 54.16 32.90 45.19 91.04 48.32 41.36

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
ASSETS
Non-Current Assets + 22,622.51 20,865.88 18,344.32 0.00 0.00 0.00 0.00
Property, Plant & Equipment 12,189.43 11,545.51 7,995.38 0.00 0.00 0.00 0.00
Capital Work in Progress 3,266.00 2,739.39 4,496.40 0.00 0.00 0.00 0.00
Non-Current Investments 206.16 226.87 301.74 0.00 0.00 0.00 0.00
Goodwill 618.02 595.15 596.07 0.00 0.00 0.00 0.00
Other Intangible Assets 1,986.74 2,352.13 2,432.24 0.00 0.00 0.00 0.00
Current Assets + 27,162.46 23,771.92 21,545.67 0.00 0.00 0.00 0.00
Inventories 10,543.72 9,808.23 8,511.23 0.00 0.00 0.00 0.00
Trade Receivables 5,745.93 4,816.74 4,466.38 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 5,568.95 3,393.48 4,396.29 0.00 0.00 0.00 0.00
Current Investments 0.01 50.58 151.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 58.08 58.59 58.59 0.00 0.00 0.00 0.00
Other Equity 32,595.24 29,784.21 26,781.26 0.00 0.00 0.00 0.00
Non-Current Liabilities 2,455.70 3,021.58 1,544.36 0.00 0.00 0.00 0.00
Current Liabilities 14,682.34 12,199.13 11,493.78 0.00 0.00 0.00 0.00
Total Liabilities 17,138.04 15,220.71 13,038.14 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
Cash from Operating Activities 3,924.62 2,434.52 2,386.75 5,016.48 0.00 0.00 0.00
Cash from Investing Activities -1,875.14 -4,255.95 -3,977.75 -3,214.81 0.00 0.00 0.00
Cash from Financing Activities 119.78 800.42 1,814.41 -2,969.27 0.00 0.00 0.00
Net Increase/Decrease in Cash 2,178.36 -1,006.84 223.35 -1,167.40 0.00 0.00 0.00